191 Folgen

  1. Recently Approved Drugs: Durvalumab for patients with stage III Non-Small Cell Lung Cancers (NSCLC)

    Vom: 27.6.2018

  2. Self-Evaluation: Special histologies - lymphoma: Primary CNS, appropriate first line therapy for newly diagnosed primary CNS lymphoma

    Vom: 20.6.2018

  3. ASCO Guideline: Fertility Preservation in Patients with Cancer

    Vom: 13.6.2018

  4. Self-Evaluation: EGFR Mutation

    Vom: 6.6.2018

  5. Recently Approved Drugs: Olaparib for germline BRCA-mutated metastatic breast cancer

    Vom: 30.5.2018

  6. ASCO Guidelines: Outpatient Management of Fever and Neutropenia

    Vom: 23.5.2018

  7. Self-Evaluation: NSCLC Treatment Metastatic

    Vom: 16.5.2018

  8. Adjuvant Treatment in Melanoma: Recent Advances

    Vom: 9.5.2018

  9. Recently Approved Drugs: Blinatumomab for B-cell precursor ALL

    Vom: 2.5.2018

  10. Guidelines: Management of Immune-Related Adverse Events

    Vom: 25.4.2018

  11. Treatment Effects & Transition to Survivorship for AYA Patients

    Vom: 18.4.2018

  12. EHR Chemotherapy Error: Breast Cancer

    Vom: 11.4.2018

  13. Continuity of Care for AYAs

    Vom: 4.4.2018

  14. Self-Evaluation: Clinical Trials Informed Consent Process

    Vom: 28.3.2018

  15. Self-Evaluation: Clinical Trials

    Vom: 14.3.2018

  16. Self-Evaluation: NSCLC

    Vom: 14.2.2018

  17. Self-Evaluation: Breast Cancer

    Vom: 7.2.2018

  18. Self-Evaluation: Metastatic Breast Cancer

    Vom: 13.12.2017

  19. ASCO Guidelines: Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer Update

    Vom: 6.12.2017

  20. Recently Approved Drugs: Nivolumab for Metastatic Colorectal Cancer

    Vom: 22.11.2017

9 / 10

ASCO Education: By the Book features engaging discussions between editors and authors from the ASCO Educational Book. Hear nuanced views on topics featured in Education Sessions at ASCO meetings and deep dives on the approaches shaping modern oncology that have care teams talking.

Visit the podcast's native language site